Acetyl-l-carnitine (ALCAR) for the prevention of chemotherapy-induced peripheral neuropathy in patients with relapsed or refractory multiple myeloma treated with bortezomib, doxorubicin and low-dose dexamethasone: a study from the Wisconsin Oncology Network
Titel:
Acetyl-l-carnitine (ALCAR) for the prevention of chemotherapy-induced peripheral neuropathy in patients with relapsed or refractory multiple myeloma treated with bortezomib, doxorubicin and low-dose dexamethasone: a study from the Wisconsin Oncology Network
Auteur:
Callander, Natalie Markovina, Stephanie Eickhoff, Jens Hutson, Paul Campbell, Toby Hematti, Peiman Go, Ronald Hegeman, Robert Longo, Walter Williams, Eliot Asimakopoulos, Fotis Miyamoto, Shigeki